Marketing Technology for Medical Device Companies: What You Actually Need

What makes medtech marketing different

Medical device companies — particularly those making Class II or Class III devices subject to 510(k) clearance or PMA approval — operate under FDA promotional regulations that constrain how they communicate about their products. Off-label promotion is prohibited. Claims must be substantiated by cleared indications. Marketing materials may need to go through medical-legal-regulatory review.

This creates a content supply chain that's significantly slower than typical B2B marketing. A case study that would take a week to produce at a SaaS company might take six weeks at a device company to get through MLR review. Website copy changes require review cycles. Promotional emails may need clearance.

The martech stack has to serve this reality — and that means prioritizing tools that help the team move within these constraints, not tools that assume a content velocity that's never going to happen.

The core stack that actually works

For most B2B medical device companies in the commercial-stage to mid-market range (10–200 employees, $5M–$100M revenue), the marketing technology stack can be surprisingly lean:

CRM: HubSpot — HubSpot's marketing, sales, and service hubs handle contact management, email marketing, landing pages, lead scoring, and sales enablement in a single platform. For medtech companies that haven't yet standardized on Salesforce, HubSpot offers strong functionality at a fraction of the implementation complexity.

Web analytics: GA4 via GTM — GA4, installed through GTM with appropriate consent configuration, provides the traffic and behavior analytics most medtech marketing teams need. The caveat: if your website includes any patient-facing content or functionality, review the HIPAA considerations discussed in my HIPAA and web analytics guide.

CMS: Webflow or WordPress — both support the content velocity and structure typical in medtech, and both are compatible with HubSpot forms and GA4. Webflow's visual editor works well for teams that rely on external design and development support. WordPress's content editor works better for teams that publish internally.

Marketing automation: HubSpot Workflows — for most medtech companies, HubSpot's built-in workflow automation is sufficient for lead nurture, sales sequences, and internal notifications. Adding Marketo or Pardot before you've saturated HubSpot's capabilities is premature optimization.

Tools that are often overkill

Enterprise ABM platforms (6sense, Demandbase) — These tools are designed for companies running large-scale, data-driven account-based marketing programs. At a cost of $60,000–$200,000 per year, they require a team and program maturity to generate ROI. Most medtech companies adopting ABM for the first time don't have the infrastructure to use these platforms effectively. Start with HubSpot's ABM features and LinkedIn-based targeting before committing to an enterprise platform.

Content management platforms for MLR review (Veeva PromoMats, etc.) — Veeva is the standard in pharma and large medical device. For earlier-stage companies, the implementation overhead and licensing costs often exceed the problem. A structured review process using your CMS's draft/review workflow and a simple approval chain is often sufficient until you're managing hundreds of promotional pieces per quarter.

Revenue intelligence tools (Gong, Chorus) — Conversation intelligence is genuinely valuable, but it's a sales operations investment, not a marketing technology investment. If sales operations isn't going to use it actively, it's shelf ware.

Vendor agreements: more important in medtech than in SaaS

Every marketing technology vendor that processes personal data from your website visitors or contacts is a potential data processor under GDPR or business associate under HIPAA (in contexts where PHI is present). In medtech, where vendor relationships often involve contracts that go through legal review anyway, it's worth ensuring that data processing agreements are in place for every martech vendor that handles EU visitor data.

The practical audit: list every tool that receives data about your website visitors or contacts (GA4, HubSpot, your CMS, email marketing tools, chat widgets, ad pixels), and verify that each has a Data Processing Agreement available and signed. For any tool that doesn't offer a DPA, evaluate whether it should be replaced or whether the data processing it does is compliant without one (some processing doesn't require a DPA under GDPR).

The conference and trade show dimension

Medtech marketing budgets typically include a significant event component — HIMSS, RSNA, MD&M, AdvaMed, and dozens of specialty society meetings. The gap between event and digital is a common data problem: business cards from RSNA don't automatically appear in HubSpot, conversations at the booth aren't tracked, and follow-up sequences get inconsistently applied.

Closing this gap requires both process (consistent badge scanning, same-day data entry into CRM, standardized follow-up sequences) and technology (badge scanner integrations with HubSpot, event-specific UTM parameters on post-show campaigns). The technology is straightforward; the process is where it actually breaks down.

Audit your last three trade shows: how many leads were entered into the CRM within 48 hours? What percentage received a personalized follow-up within a week? What's the MQL rate from event leads versus other channels? The answers tell you whether the problem is technology or process — and they're almost always process.